Dr. Reddy's Laboratories
RDY
#1703
Rank
HK$92.06 B
Marketcap
HK$110.08
Share price
0.07%
Change (1 day)
0.22%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): HK$7.16 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are HK$3.95 Billion. In 2024 the company made an earning of HK$6.98 Billion, an increase over its 2023 earnings that were of HK$6.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$7.16 B2.47%
2024 HK$6.98 B7.01%
2023 HK$6.53 B17.62%
2022 HK$5.55 B43.27%
2021 HK$3.87 B31.44%
2020 HK$2.94 B54.54%
2019 HK$1.90 B-14.21%
2018 HK$2.22 B26.15%
2017 HK$1.76 B4.69%
2016 HK$1.68 B-55.7%
2015 HK$3.80 B1.83%
2014 HK$3.73 B-3.78%
2013 HK$3.88 B54.07%
2012 HK$2.51 B-16.23%
2011 HK$3.00 B56.66%
2010 HK$1.91 B-235.36%
2009 -HK$1.42 Billion-198.53%
2008 HK$1.43 B30.77%
2007 HK$1.10 B-14.61%
2006 HK$1.28 B703.63%
2005 HK$0.16 B649.45%
2004 HK$21.39 M-95.68%
2003 HK$0.49 B-14.86%
2002 HK$0.58 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.26 B 1,189.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$13.79 B 92.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$72.57 B 914.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
HK$127.81 B 1,686.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$70.84 B 890.26%๐Ÿ‡ซ๐Ÿ‡ท France